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The bacterial pathogen Edwardsiella ictaluri causes enteric septicemia of catﬁsh (ESC), an economically signiﬁcant disease of farm-raised channel
catﬁsh. Commercial catﬁsh production accounts for the majority of the total ﬁn
ﬁsh aquaculture in the United States, with almost 300,000 tons produced annually, and ESC is the leading cause of disease loss in the industry. We have demonstrated the survival and replication of E. ictaluri within channel catﬁsh cells
and identiﬁed a secretion system that is essential for E. ictaluri intracellular replication and virulence. We have also identiﬁed nine proteins encoded in the E. ictaluri genome that we believe are actively transferred from the bacterium to the
cytoplasm of the host cell and act to manipulate host cell physiology to the advantage of the bacterium. The data presented here conﬁrm that the proteins are
actually transferred during an infection, which will lead to further work on approaches to preventing or controlling ESC.
IMPORTANCE
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ABSTRACT
Edwardsiella ictaluri, a major pathogen in channel catﬁsh aquaculture,
encodes a type III secretion system (T3SS) that is essential for intracellular replication
and virulence. Previous work identiﬁed three putative T3SS effectors in E. ictaluri,
and in silico analysis of the E. ictaluri genome identiﬁed six additional putative effectors, all located on the chromosome outside the T3SS pathogenicity island. To establish active translocation by the T3SS, we constructed translational fusions of each effector to the amino-terminal adenylate cyclase (AC) domain of the Bordetella
pertussis adenylate cyclase toxin CyaA. When translocated through the membrane of
the Edwardsiella-containing vacuole (ECV), the cyclic AMP produced by the AC domain in the presence of calmodulin in the host cell cytoplasm can be measured. Results showed that all nine effectors were translocated from E. ictaluri in the ECV
to the cytoplasm of the host cells in the wild-type strain but not in a T3SS mutant, indicating that translocation is dependent on the T3SS machinery. This conﬁrms that the E. ictaluri T3SS is similar to the Salmonella pathogenicity island 2
T3SS in that it translocates effectors through the membrane of the bacterial vacuole directly into the host cell cytoplasm. Additional work demonstrated that
both initial acidiﬁcation and subsequent neutralization of the ECV were necessary for effector translocation, except for two of them that did not require neutralization. Single-gene mutants constructed for seven of the individual effectors
were all attenuated for replication in CCO cells, but only three were replication
deﬁcient in head kidney-derived macrophages (HKDM).

Dubytska et al.

he Gram-negative bacterial pathogen Edwardsiella ictaluri causes enteric septicemia
of catﬁsh (ESC), an economically signiﬁcant disease of farm-raised channel catﬁsh,
Ictalurus punctatus. Commercial catﬁsh production accounts for 85 to 90% of the total
ﬁn ﬁsh aquaculture in the United States, with about 300 million lbs. produced in 2014
(1). Edwardsiella ictaluri is the leading cause of disease loss in the catﬁsh industry,
accounting for an estimated 20% loss in 2009 (2). The survival and replication of
E. ictaluri in channel catﬁsh head kidney-derived macrophages (HKDM) (3) and a
channel catﬁsh ovary (CCO) cell line (4) were reported (5), and a type III secretion
system (T3SS) that is essential for E. ictaluri virulence and intracellular replication was
identiﬁed (5). Type III secretion systems are complex protein machines that form a
needle-like structure that is able to translocate effector proteins across both the
Gram-negative cell wall and the host cell membrane, directly from the bacterial
cytoplasm to the cytosol of the host cell (6–10). Although the structural proteins of
T3SSs are quite conserved in bacterial pathogens, the arsenal of translocated effector
proteins delivered to the host is unique to each system. Thus, the effect that a T3SS has
on the host varies depending on the pathogen in question, and pathogenesis is deﬁned
by the particular set of effectors produced by that pathogen. Reported T3SS functions
range from intracellular uptake, surface colonization of the cell without uptake, adherence to macrophages, and inhibition of phagocytosis, cytotoxicity, vesicular trafﬁcking,
programed cell death, and up- or downregulation of inﬂammatory cytokines and gene
expression (8, 11, 12).
Most T3SSs translocate effectors from outside the host cell across the cell membrane
into the cytoplasm. Like the Salmonella pathogenicity island 2 (PAI 2) T3SS, however,
the E. ictaluri T3SS translocates effectors to the host cell cytosol through the vacuolar
membrane. Previous work to evaluate the development of the E. ictaluri-containing
vacuole (ECV) showed that acidiﬁcation of the ECV by vacuolar H⫹ ATPases was
required for E. ictaluri to replicate in HKDM (13, 14). Acidiﬁcation also resulted in
activation of the E. ictaluri urease enzyme, which utilized urea produced by the
HKDM-encoded arginase enzyme to produce ammonia, which resulted in subsequent
neutralization of the ECV (14, 15). Both acidiﬁcation and subsequent neutralization of
the ECV are required for E. ictaluri to replicate in HKDM (13, 15).
Three putative effectors are reported for E. ictaluri, one in the T3SS PAI (5) and one
on each of the E. ictaluri plasmids pEI1 (16) and pEI2 (5). Given the importance of T3SS
effectors to virulence in other bacterial pathogens and the requirement for an intact
T3SS for E. ictaluri virulence, an in silico study was conducted to identify additional
effectors and to identify conserved domains and motifs that provided insight into
possible function. Then, to evaluate active translocation of the putative E. ictaluri
effectors to the cytosol of HKDM and CCO cells and to examine the possible role of ECV
pH changes on translocation, we constructed translational fusions to the aminoterminal adenylate cyclase (AC) domain of the Bordetella pertussis adenylate cyclase
toxin CyaA. The AC domain of the CyaA toxin was used as a reporter to demonstrate
type III translocation of effector proteins in a number of Gram-negative pathogens, and
this process is the method of choice for studying the translocation of T3SS effectors
(17–20). The assay is based on the measurement of cyclic AMP (cAMP) produced by the
interaction of the translocated AC domain and calmodulin, which is present in the
HKDM cytoplasm but not in the ECV. The primary objectives of this study were to
identify additional T3SS effectors of E. ictaluri, demonstrate active translocation of all
known E. ictaluri effectors by the T3SS apparatus, establish the pH conditions conducive
to translocation, and establish a role in intracellular replication for the individual
effectors.
RESULTS
In silico analysis. Edwardsiella ictaluri encodes at least nine putative effectors with
homology to effectors in other pathogens (Table 1). The previously reported leucinerich repeat (LRR) effector EseH is on the E. ictaluri native plasmid pEI (16). The four LLR
effectors reported here, EseJ, EseK, EseL, and EseM, were identiﬁed by Basic Local
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TABLE 1 Putative T3SS effectors identiﬁed for Edwardsiella ictaluri
Effector
EseG
EseH
EseI
EseJ
EseK
EseL
EseM
EseN
EseO

GenBank accession no. Size (aa) Putative activity/description (reference)a
ABC60070
301
Vacuolar localization (5)
AAF85955
619
LRR, 5 repeats, E3 ubiquitin ligase (16)
AGF34188
151
Shigella OspB family of T3SS effectors (16)
ACR69526
599
LRR, 12 repeats, E3 ubiquitin ligase
LRR, 18 repeats, E3 ubiquitin ligase
Genomeb
ACR68523
705
LRR, 6 repeats, E3 ubiquitin ligase
ACR68525
793
LRR, 11 repeats, E3 ubiquitin ligase
ACR69124
214
Phosphothreonine lyase domain
ACR69900
667
Shigella enterotoxin 2 and ankyrin repeat protein

aLRR,

leucine-rich repeat protein.
was identiﬁed during E. ictaluri genome sequencing but was not found in the ﬁnal assembly. Analysis
by PCR conﬁrmed its presence in the genome, and it was cloned using the sequence from the original
contig.

Alignment Search Tool (BLAST) analysis of the E. ictaluri genome using the EseH
sequence as the query. All four effectors are encoded in the E. ictaluri chromosome but
not within the T3SS PAI. Domain analyses of the ﬁve E. ictaluri LRR effectors indicated
that the amino termini contain a translocation domain which has 53.5 to 67.7% amino
acid identity (I) to, 79.4 to 88.0% amino acid similarity (S) to, and 100% query coverage
(QC) of the translocation domain reported for the LRR effector SspH2 in Salmonella (21).
The E. ictaluri translocation domains for the ﬁve LRR effectors have 51.9 to 82.5% I and
79.4 to 93.2% S to each other. Comparison of the central LRR regions showed that EseH
contains 5 leucine-rich repeats in the core of the protein, while EseJ, EseK, EseL, and
EseM have 12, 18, 6, and 11 repeats, respectively. All ﬁve of the E. ictaluri LRR effectors
contain an E3 ubiquitin ligase domain in their carboxy terminus.
The previously described effector encoded on the E. ictaluri native plasmid pEI2 (5),
EseI, has 30 to 50% I and 45 to 66% S to a family of hypothetical/putative proteins with
similarity to OspB in Shigella. QC ranged from 26 to 90%, and protein analysis indicated
no conserved domains or repeats. Two other E. ictaluri effectors with homology to
those in Shigella were identiﬁed during annotation of the E. ictaluri genome. EseN has
similarity to a family of T3SS effectors that carry a phosphothreonine lyase domain.
EseO has homology to a family of proteins with similarity to OspD3 in Salmonella and
carries the amino terminus of the ShET2 enterotoxin domain; with that family, it shows
30 to 77% I, 60 to 80% S, 37 to 99% QC, and an ankyrin repeat (ANK) domain. Finally,
the only E. ictaluri effector encoded on the T3SS PAI is EseG, with 25 to 71% I to, 52 to
79% S to, 34 to 94% QC of the PRK15357 superfamily of T3SS effectors like SseG in
Salmonella.
In vitro protein secretion following a pH shift from 5 to 7. As indicated in
Fig. 1A, the shift from pH 5 to pH 7 in MMP increased total protein secretion by
E. ictaluri 10-fold compared to that in the culture kept at pH 5. As conﬁrmation that this
increase is due to increased T3SS effector release, the E. ictaluri effector-CyaA strains all
showed an increase in release following a shift from pH 5 to pH 7 when examined in
Western blots using CyaA antibody, although EseG, EseM, EseN, and EseI were also
released at pH 5 in reduced quantities (Fig. 1B). EseH, EseM, and EseL were substantially
absent in the pellet at either pH, suggesting that they were secreted as they were being
translated. Effector secretion was not detected in the E. ictaluri strain that did not
harbor a CyaA fusion.
Translocation assay. Based on the production of cAMP in the translocation assay,
all E. ictaluri effector-CyaA fusions were translocated to the host cell cytoplasm at 7 h
postinfection (p.i.) in both HKDM and CCO cells (Fig. 2). No cAMP production was
detected in HKDM infected with the wild-type E. ictaluri strain or the T3SS knockout
strain carrying the effector-CyaA constructs (data not shown). Truncation of the LRR
effectors to the ﬁrst 200 to 267 amino acids (aa) did not abolish translocation and
resulted in greater translocation levels than in a construct carrying the entire gene (data
not shown), conﬁrming that the amino-terminal region contains the sequence responVolume 1 Issue 3 e00039-16
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FIG 1 (A) Total protein secreted when E. ictaluri was grown overnight in MMP, pH 5, and moved to
fresh MMP, pH 5. After 4 h, one tube was adjusted to pH 7, and both tubes were incubated for an
additional 90 min, after which the supernatant and cell pellet fractions were separated by centrifugation. (B) Immunoblot of the supernatant and cell pellet fractions with anti-CyaA to detect the
E. ictaluri T3SS effector-CyaA fusions. WT, wild type.

sible for translocation. The negative-control fusions for EscD and ExoY were negative
for cAMP production despite the presence of the AC domain of CyaA.

baﬁlomycin A1 to block acidiﬁcation of the ECV resulted in a complete loss of fusion
protein translocation at 5 h p.i. (Fig. 3). Treatment of the cultures with the speciﬁc
arginase inhibitor norvaline also resulted in a signiﬁcant reduction in translocation for
all effector-CyaA fusions except for EseG and EseN at 5 h p.i. (Fig. 4). This indicates that
both acidiﬁcation and subsequent neutralization of the ECV are required for the
translocation of all of the effectors except EseG and EseN.

Replication in channel catﬁsh macrophages and channel catﬁsh ovary
cells. As indicated in Fig. 5, single-gene mutations of each individual effector had
differential effects on intracellular replication. Only EseJ, EseK, and EseN had a signiﬁcant reduction in replication in HKDM. In the nonphagocytic CCO cell line, however, all
seven tested effector mutants replicated at a signiﬁcantly lower rate than the wild type.
Complementation of EseG and EseJ in CCO cells was relatively low at 17 and 15%, while
that of EseK, EseL, EseM, EseN, and EseO was 21, 36, 22, 35, and 24%, respectively. All

FIG 2 Translocation of the E. ictaluri effector-CyaA fusions as indicated by cAMP production in HKDM and CCO
cells 7 h postinfection. Fusions for the nontranslocated escD and exoY genes were zero despite the presence
of the fused AC domain of cyaA. The T3SS mutants carrying the effector-CyaA fusions were all negative for
cAMP production (data not shown), indicating that translocation is a T3SS-dependent event. Effectors whose
designations are preceded with a “t” are the leucine-rich repeat effectors that were truncated to leave only the
translocation domain.
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Effector translocation requires acidiﬁcation and subsequent neutralization
of the ECV. Treatment of HKDM with the speciﬁc vacuolar proton pump inhibitor
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FIG 3 Inhibition of the vacuolar (Hⴙ) ATPases of HKDM by the specific inhibitor bafilomycin A1 to

three of the effectors with attenuated replication in the HKDM, EseJ, EseK, and EseN,
were returned to wild-type levels of replication in complemented strains. All seven had
signiﬁcantly greater replication than 65ST, which has a mutation in eseU, which encodes
a major protein of the injectisome and is unable to translocate effector proteins out of
the bacterial cell, as demonstrated in Fig. 2.
DISCUSSION
The primary objectives of this study were to conduct an in silico analysis to identify and
characterize the structures of the T3SS effectors of E. ictaluri, to evaluate conditions for

FIG 4 Inhibition of the HKDM-encoded arginase enzyme by the specific inhibitor norvaline to
prevent neutralization of the acidified ECV inhibits the translocation of most of the effectors, as
indicated by reduced cAMP production in HKDM at 5 h postinfection. Results are presented as means
and standard errors of the means and are combined data from three identical experiments with two
replications per treatment per experiment. Asterisks indicate a significant difference from the
nontreated controls (**, P < 0.01; ***, P < 0.001). P values for Ln and On could not be calculated
because all of the values were 0. Effectors whose abbreviations are preceded with a “t” are the
leucine-rich repeat effectors that were truncated to leave only the translocation domain, and those
whose abbreviations end with an “n” were treated with norvaline.
Volume 1 Issue 3 e00039-16
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prevent acidification of the ECV totally inhibits the translocation of the E. ictaluri T3SS effector-CyaA
fusions, as indicated by the lack of cAMP production in treated HKDM at 5 h postinfection compared
to that in untreated cultures. The designations for effectors are abbreviated to just their loci.
Effectors whose designations are preceded with a “t” are the leucine-rich repeat effectors that were
truncated to leave only the translocation domain, and those whose designations end with a “b” were
treated with bafilomycin A1.

Dubytska et al.

their active translocation from the bacterium in the ECV to the host cell cytoplasm, and
to establish their role in intracellular replication. The in silico analyses identiﬁed six new
putative E. ictaluri T3SS effectors, bringing the total to nine. Five of the nine identiﬁed
effectors, namely, EseH, EseJ, EseK, EseL, and EseM, have a translocation domain in the
amino terminus, carry leucine-rich repeats (LRRs) in the central portion of the protein,
and have E3 ubiquitin ligase domains in their carboxyl terminus. Leucine-rich repeats
are widespread structural motifs that are found in thousands of protein sequences in
all life forms, from viruses to eukaryotes (22). Despite having a wide range of functions
(22, 23), LRR proteins share a structural framework, consisting of a curved solenoid
structure encompassing the LRR sequence, that presents an ideal structure for ligand
binding (24–26). Proteins in the LRR family form tight associations with their respective
protein ligands, and the speciﬁc shape of the particular curved solenoid, as determined
by the sequences of the repeats and the number of repeats, determines the protein
speciﬁcity. The various lengths of the E. ictaluri LRR regions indicate that their solenoid
structures differ, suggesting diverse types of protein binding.
As stated above, the ﬁve E. ictaluri LRR effectors also carry E3 ubiquitin ligase
domains. Ubiquitin is a highly conserved 76-aa protein that controls almost all aspects
of a cell’s life and death through a process known as ubiquitination, a process involving
reversible covalent modiﬁcations of cellular proteins (27, 28) that is similar to phosphorylation. Ubiquitination consists of the covalent attachment of ubiquitin to lysine
residues on a target protein by ubiquitin ligases (29). The number and locations of the
attached moieties determine whether the protein is targeted for degradation by the
proteosome or functions as a nonproteolytic signal for DNA repair, signal transduction,
or vesicular trafﬁcking (30–34). The presence of ubiquitin ligase domains on the ﬁve
E. ictaluri LRR effectors predicts that they play an important role in determining the fate
of the protein bound in the solenoid structure.
The chromosomal effector EseN, one of the four non-LRR effectors, has high
homology to the OspF family of T3SS effectors, which includes OspF in Shigella, SpvC
in Salmonella, and HopA11 in Pseudomonas (35), as well as 95 others identiﬁed in a
BLAST search of microbial genomes. Members of the OspF family act as phosphothreonine lyases (PTL), which catalyze the removal of the phosphate group of phosphothreonine in the pT-X-pY motif of phosphorylated mitogen-activated protein kinases
(MAPK), preventing downstream phosphorylation of histone H3 and downregulating
transcription of proinﬂammatory cytokines, resulting in attenuation of the host inﬂammatory response (36). EseN also carries the GDKXH motif, which is required for PTL
Volume 1 Issue 3 e00039-16
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FIG 5 Replication of Edwardsiella ictaluri strains carrying mutations in T3SS effector genes in HKDM and CCO
cells at 10 h postinfection. Bars indicate relative indexes of replication, which were calculated by dividing the
number of CFU in the wild type and the individual mutants by the number of CFU present in the wild type.
Results are presented as means and standard errors of the means and are combined data from three identical
experiments, with 3 replications per treatment per experiment (*, P < 0.1; **, P < 0.01; ***, P < 0.001).
Complementation of EseG and EseJ in CCO cells was relatively low, at 17 and 15%, while those of EseK, EseL,
EseM, EseN, and EseO were 21, 36, 22, 35, and 24%, respectively. All three of the effectors with attenuated
replication in HKDM, i.e., EseJ, EseK, and EseN, were returned to wild-type levels of replication in complemented strains.

activity (35), as well as the highly conserved D motif for MAPK substrate docking in the
amino terminus (35), suggesting a function for EseN similar to those of the other
members of the family.
EseO, a second non-LRR effector, is also located on the E. ictaluri chromosome, and
BLAST analysis identiﬁed two conserved domains, Shigella enterotoxin 2 (ShET2) and
ankyrin repeats (ANKs). ShET2 is a widespread domain in Shigella and Escherichia coli
that is responsible for causing diarrhea (37, 38) but also for upregulating interleukin 8
(IL-8) secretion in epithelial cells in Shigella (39). Ankyrin repeats are common proteinprotein interaction motifs in a wide variety of eukaryotic and prokaryotic proteins,
including a diverse family of type IV secretion system effectors (40). This is the ﬁrst
report of an ANK protein being translocated by a T3SS.
Both SseG and SseF are encoded on the chromosome in the Salmonella pathogenicity island 2 (SPI-2) T3SS PAI of Salmonella. In epithelial cells, SseG and SseF are
involved in placement of the developing Salmonella-containing vacuoles (SCVs) adjacent to the nucleus, locating in the region of the microtubule-organizing center and
associated Golgi stacks, a location that is required for Salmonella replication (41, 42).
Single SseG and SseF mutants have similar levels of attenuation in mice and growth
attenuation in macrophages (43, 44), but SseG SseF double mutants remain as virulent
as the single mutants (45). The similarity of the virulence of the single mutants and the
lack of an additive effect on virulence in the double mutant, along with the 30%
similarity of the amino acid sequences, suggest that SseG and SseF have redundant
functions and that E. ictaluri EseG alone is sufﬁcient to achieve the same result as SseF
SseG in Salmonella. Edwardsiella tarda EseG triggers microtubule destabilization in
human embryonic kidney 293 (HEK293A) cells, but positioning of the vacuole was not
evaluated (46).
Based on immunoﬂuorescence and cell fractionation assays in the zebraﬁsh ZF4
ﬁbroblast cell line, E. ictaluri EseI appeared to localize to the cytosolic fraction when it
was expressed in E. tarda. Adhesion studies of epithelioma papulosum cyprini (EPC)
carp cells further suggested that EseI was involved in adhesion and invasion of that cell
type (47). Expression of E. ictaluri EseI in the surrogate E. tarda makes it difﬁcult to
interpret these conclusions regarding the function of EseI in light of the data that
suggest that the Shigella homologue of EseI, OspB, functions as an immunomodulator
(48, 49), not an adhesion molecule.
The T3SS-encoded regulatory proteins EsrABC upregulate expression of the components of the T3SS that are encoded on of the PAI in response to low pH and low
phosphate in minimal media (50). Plasmid-encoded EseI, however, is also upregulated
by low pH and low phosphate in minimal media but not in an EsrABC-dependent
manner (50). EseI was also secreted when it was expressed in E. tarda but not in a
T3SS-dependent manner (47). Although these data suggest that EseI secretion in media
is not linked to the T3SS, the ex vivo data presented here showing that EseI is
translocated in wild-type E. ictaluri but not in the T3SS knockout mutant 65ST indicates
that the T3SS is required for translocation in E. ictaluri HKDM and the CCO cell line. Zhao
et al. (47) also demonstrated that EseI was translocated in the mammalian J774
macrophage cell line but did not report data for translocation in a T3SS mutant.
Baumgartner et al. (13) previously demonstrated that the development of the ECV
involves initial acidiﬁcation of the ECV by vacuolar H⫹ ATPases, which triggers expression of the T3SS (50) and activates the E. ictaluri acid-activated urease (15). Activation
of the urease results in the production of ammonia by means of urea produced by the
HKDM-encoded arginase enzyme, which results in an increase in the pH of the ECV (13).
Results presented here demonstrate that both acidiﬁcation and neutralization of the
ECV are required to trigger the translocation of the E. ictaluri effectors, which is unique
among bacterial pathogens. As with the E. ictaluri T3SS, transcription and assembly of
the related Salmonella SPI-2 T3SS requires acidiﬁcation of the SCV, but the SCV remains
acidiﬁed. The signal for translocation, however, is also recognition of a neutral pH, but
the signal recognized is the neutral pH of the cytoplasm by the effectors SsaM, SpiC,
and SsaL (51), which do not have homologues in the E. ictaluri genome.
Volume 1 Issue 3 e00039-16
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Attenuation of intracellular replication of the individual effector mutants is most
pronounced in the CCO cell line, with all seven effector mutants demonstrating
signiﬁcant reductions in intracellular growth. This is in contrast to the impact in HKDM,
in which only EseJ, EseK, and EseN were signiﬁcantly attenuated, and the level of
attenuation was less than in the CCO cells. The negligible effect of only three of the
single-effector mutants in HKDM, compared to the severe replication defect of an
apparatus mutant, 65ST, which precludes the translocation of any effectors, may
suggest the presence of additional effectors in the E. ictaluri genome that have a role
in intracellular replication in HKDM. The differential levels of attenuation for intracellular replication between HKDM and CCO cells may indicate differential modes of action
in the 2 cell types. Further work to establish the biochemical and physiological activities
of the individual effectors in both HKDM and CCO cells is required.

In silico analysis. BLAST was used to align the three putative effectors previously identiﬁed for E. ictaluri
to the genomic sequence of E. ictaluri (GenBank accession number CP001600) in order to identify
additional effectors. ClustalX was used for multiple-sequence alignments of DNA and protein sequences.
The InterPro database (http://www.ebi.ac.uk/Tools/pfa/iprscan/) was used for possible protein family
identiﬁcation and to identify conserved domains within the protein sequence.
Bacterial strains, plasmids, and media. Strains and plasmids used in this study are listed in Table 2.
Edwardsiella ictaluri strains were grown at 28°C on either Trypticase soy agar plates supplemented with
5% sheep blood (BA; Remel Products, Lenexa, KS) or porcine brain heart infusion (BHI) agar (BD Difco,
Lawrence, KS). Broth cultures of E. ictaluri were grown in either porcine BHI broth or E. ictaluri
low-phosphate minimal medium (MMP) (50, 52). Escherichia coli strains were cultured using LB broth or
agar at 37°C (BD Difco). All cultures grown in broth were aerated on a Cel-Gro tissue culture rotator
(Lab-Line, Inc., Melrose Park, IL). Antibiotics were added where appropriate in the following concentrations: for ampicillin (Amp), 200 g/ml, and for colistin (Col), 20 g/ml (Sigma).
SPF channel catﬁsh. Channel catﬁsh egg masses obtained from production facilities with no history
of E. ictaluri outbreaks were disinfected with 100 ppm free iodine and were hatched and reared in closed
recirculating aquaculture systems in the speciﬁc-pathogen-free (SPF) aquatic laboratory at the LSU
School of Veterinary Medicine. Catﬁsh used for harvesting macrophages were reared in the SPF lab and
were between 500 and 750 g. All animal work was conducted under protocols approved by the
Institutional Animal Care and Use Committee.
DNA manipulations. DNA manipulations were performed by standard methods. All enzymes used
in plasmid construction were obtained from New England Biolabs (Beverly, MA). Total DNA was puriﬁed
from cultures using the High Pure PCR template preparation kit (Roche, Mannheim, Germany). Phusion
high-ﬁdelity polymerase (Thermo Scientiﬁc, Waltham, MA) was used for PCR ampliﬁcations. DNA restriction fragment isolation and PCR product puriﬁcation were done by using the QIAquick gel extraction kit
(Qiagen, Valencia, CA). All procedures were performed according to the manufacturer’s instructions.
Oligonucleotide primers were purchased from Integrated DNA Technologies (Coralville, IA). All constructs
were conﬁrmed by PCR and DNA sequencing. All DNA work was conducted under protocols approved
by the Inter-Institutional Biological and Recombinant DNA Safety Committee of Louisiana State University.
Effector-CyaA fusion and effector mutant construction. The strategy for constructing the effectorCyaA fusions is depicted in Fig. 6. Brieﬂy, each effector was ampliﬁed with a gene-speciﬁc forward primer,
P1, that annealed at least 300 bp upstream from the translational start codon in order to incorporate the
native promoter and included a linker containing a speciﬁc restriction enzyme (RE) site to facilitate
cloning. Primer P1 was paired with the reverse primer, P2, which included a linker that contained 25 to
30 bp of the AC domain of CyaA. The 1,197-bp AC domain of CyaA from bp ⫹4 to ⫹1227 was ampliﬁed
from the plasmid pMJH20 (17) with primer P3, which included 25 to 30 bp of the speciﬁc effector, and
primer P4, which included an in-frame stop codon and the rho-independent transcriptional terminator
from the Bacillus subtilis yqfT gene (53) and another RE site. Both eseI and eseG were ampliﬁed to include
their respective chaperones, escD and escB. Because fusion of CyaA to the intact effectors carrying
leucine-rich repeats (LRRs) resulted in poor translocation, the fusions for the ﬁve LRR proteins were
constructed with reverse primers that ampliﬁed approximately 200 amino acids of the amino terminus,
removing the LRR region and the carboxy terminus from the fusion construct. To serve as negative
controls, CyaA fusions were also constructed for the chaperone for EseH, namely, EscD, and the E. ictaluri
adenylate cyclase ExoY, neither of which should be translocated. Primers used to amplify the AC domain
of CyaA and the individual effectors are listed in Table 3. To produce the fusion constructs, the effector
and CyaA amplicons were mixed and ampliﬁed using primers P1 and P4, and the construct was cloned
into the plasmid pBBR1MCS-4 (54). The resulting plasmids were transformed into E. coli S17-1 -pir (55)
and transferred to E. ictaluri by conjugation (56).
Individual effector mutants were constructed in a similar manner except that primers P1 and P2
ampliﬁed from the amino terminus to bp 500 to 900 of the ﬂanking sequence of the effector and primers
P3 and P4 ampliﬁed from the carboxy terminus to bp 500 to 900 of the ﬂanking sequence. Primers P1
and P4 contained selected restriction endonucleases to facilitate ﬁnal cloning of the gene-deleted
fragment. Primer P2 included overlapping sequence of the right arm, and P3 contained overlapping
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MATERIALS AND METHODS

Edwardsiella ictaluri Translocated Effectors

Strain or plasmid
Strains
E. coli S17 -pir
E. ictaluri
93-146

65ST
93-146 eseG::cyaA
Δ65 ST eseG::cyaA
93-146 teseH::cyaA
Δ65 ST teseH::cyaA
93-146 eseI::cyaA
Δ65 ST eseI::cyaA
93-146 teseJ::cyaA
Δ65 ST teseJ::cyaA
93-146 teseK::cyaA
Δ65 ST teseK::cyaA
93-146 teseL::cyaA
Δ65 ST teseL::cyaA
93-146 teseM::cyaA
Δ65 ST teseM::cyaA
93-146 eseN::cyaA
Δ65 ST eseN::cyaA
93-146 eseO::cyaA
Δ65 ST eseO::cyaA
ΔG
ΔJ
ΔK
ΔL
ΔM
ΔN
ΔO
Plasmids
pEI1
pEI2
pMJH20
pBBR1MCS-4
pBBR1-eseG::cyaA
pBBR1-eseI::cyaA
pBBR1-eseO::cyaA
pBBR1-eseN::cyaA
pBBR1-eseG::cyaA
pBBR1-teseH::cyaA
pBBR1-eseI::cyaA
pBBR1-teseJ::cyaA
pBBR1-teseK::cyaA
pBBR1-teseL::cyaA
pBBR1-teseM::cyaA
pRE107-ΔeseG
pRE107-ΔeseJ
pRE107-ΔeseK
pRE107-ΔeseL
pRE107-ΔeseM
pRE107-ΔeseN
pRE107-ΔeseO
pBBR1-eseG
pBBR1-eseJ
pBBR1-eseK
pBBR1-eseL
pBBR1-eseM
pBBR1-eseN
pBBR1-eseO

Relevant characteristic(s)a

Reference or source

(F⫺) RP4-2-Tc::Mu aphA::Tn7 recA -pir

61

Wild-type E. ictaluri isolated from a moribund
channel catﬁsh from a natural outbreak at a
commercial facility in 1993
93-146 esaU::Tn5Km2
Carrying pBBR1, eseG::cyaA Ampr
Carrying pBBR1, eseG::cyaA Ampr
Carrying pBBR1, truncated eseH::cyaA, Ampr
Carrying pBBR1, truncated eseH::cyaA, Ampr
Carrying pBBR1, eseI::cyaA Ampr
Carrying pBBR1, eseI::cyaA Ampr
Carrying pBBR1, truncated eseJ::cyaA, Ampr
Carrying pBBR1, truncated eseJ::cyaA, Ampr
Carrying pBBR1, truncated eseK::cyaA, Ampr
Carrying pBBR1, truncated eseK::cyaA, Ampr
Carrying pBBR1, truncated eseL::cyaA, Ampr
Carrying pBBR1, truncated eseL::cyaA, Ampr
Carrying pBBR1, truncated eseM::cyaA, Ampr
Carrying pBBR1, truncated eseM::cyaA, Ampr
Carrying pBBR1, eseN::cyaA Ampr
Carrying pBBR1, eseN::cyaA Ampr
Carrying pBBR1, eseO::cyaA Ampr
Carrying pBBR1, eseO::cyaA Ampr
E. ictaluri 93-146 Δ(eseG1–773)
E. ictaluri 93-146 Δ(eseJ)
E. ictaluri 93-146 Δ(eseK1–2202)
E. ictaluri 93-146 Δ(eseL82–2094)
E. ictaluri 93-146 Δ(eseM)
E. ictaluri 93-146 Δ(eseN)
E. ictaluri 93-146 Δ(eseO1–1873)

LSU aquatic diagnostic
laboratory
5
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This

work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work

E. ictaluri 93-146 native plasmid
E. ictaluri 93-146 native plasmid
Plasmid containing CyaA adenylate cyclase
Broad-host-range expression vector
pBBR1MCS4 carrying eseG::cyaA
pBBR1MCS4 carrying eseI::cyaA
pBBR1MCS4 carrying eseO::cyaA
pBBR1MCS4 carrying eseN::cyaA
pBBR1MCS4 carrying eseG::cyaA
pBBR1MCS4 carrying truncated eseH::cyaA
pBBR1MCS4 carrying eseI::cyaA
pBBR1MCS4 carrying truncated eseJ::cyaA
pBBR1MCS4 carrying truncated eseK::cyaA
pBBR1MCS4 carrying truncated eseL::cyaA
pBBR1MCS4 carrying truncated eseM::cyaA
pRR107 with individual effector deletion
pRR107 with individual effector deletion
pRR107 with individual effector deletion
pRR107 with individual effector deletion
pRR107 with individual effector deletion
pRR107 with individual effector deletion
pRR107 with individual effector deletion
Complementation plasmid
Complementation plasmid
Complementation plasmid
Complementation plasmid
Complementation plasmid
Complementation plasmid
Complementation plasmid

16
16
17
54
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This

work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work
work

aA

subscript number range after a gene name indicates the range of base pairs left in the gene after
deletion.
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TABLE 2 Bacterial strains and plasmids used in this study

Dubytska et al.

FIG 6 Schematic describing the construction of the E. ictaluri effector mutants. The LRR effector

sequence of the left arm so that when the PCR products were mixed, they annealed to each other;
ampliﬁcation with the P1 and P4 primers resulted in a fragment with the required deletion and with
ﬂanking sequence on either side of the effector to be deleted to mediate integration of the plasmid into
the chromosome. Primers used for the construction of the single-gene effector mutants are listed in
Table 4. The deletion constructs were cloned into the suicide plasmid pRE107 (57), transformed into
E. coli S17 -pir, transferred to E. ictaluri 93-146 by conjugation, and grown in BHI-Amp to select for
plasmid integration into the chromosome. Colonies positive for Ampr were then grown in BHI with 7.5%
sucrose to select for a second crossover and excision of the plasmid, which resulted in a mixture of
wild-type and deletion mutants. Deletion mutants were identiﬁed by PCR using effector-speciﬁc primers
and conﬁrmed by DNA sequencing. Final mutant constructs consisted of complete gene deletions of
EseJ, EseM, and EseN, deletions of bp 1 to 773 of a total of 921 bp for EseG, bp 1 to 2202 of a total of
2,810 bp for EseK, bp 82 to 2094 of a total of 2,175 bp for EseL, and bp 1 to 1873 of a total of 1,979 bp
for EseO. Previous work (5) demonstrated that introduction of mutations in eseH and eseI on the E. ictaluri
plasmids resulted in the production of strains carrying 50% mutant plasmid constructs and 50%
wild-type plasmid constructs. The presence of both mutant and wild-type constructs makes interpretation of results difﬁcult, so new mutants of EseH and EseI were not constructed for use in this study.
In vitro secretion following a pH shift from 5 to 7. The E. ictaluri effector-CyaA strains and the wild
type were cultured for 16 to 18 h to an optical density at 600 nm (OD600) of 1.8 to 2.0 to achieve
maximum cell density. Cells were pelleted at 5,000 rpm for 5 min, washed once in phosphate-buffered
saline, and resuspended in 2 ml of MMP, pH 5. One milliliter of this suspension was inoculated into each
of two 5-ml tubes of MMP, pH 5, and incubated for 4 h at 28°C, after which the pH of one culture was
maintained at pH 5 while the other was adjusted to pH 7. Both were incubated an additional 90 min at
28°C, after which the cells were pelleted at 6,000 rpm for 6 min and separated into the supernatant and
cell pellet fractions. Bacterial pellets were resuspend in XT sample buffer (Bio-Rad, Hercules, CA) and
boiled for 5 min, after which 1⫻ Halt protease inhibitor (Thermo Scientiﬁc) and 25 U Pierce Universal
nuclease (Thermo Scientiﬁc) were added. Supernatants were concentrated to 100 l with a Spin-X UF6
10,000-molecular-weight-cutoff concentrator (Corning, Lowell, MA), and 25 l of XT sample buffer
(Bio-Rad) was added, after which the sample was boiled for 5 min. Halt protease inhibitor (Thermo
Scientiﬁc) was added to the supernatant fraction, and total protein was determined by using the Bio-Rad,
Bradford protein assay.
Samples were separated by SDS-PAGE on 4 to 12% polyacrylamide gradient gels and transferred onto
polyvinylidene diﬂuoride (PVDF) membranes by using the iBlot dry transfer system (Life Technologies,
Grand Island, NY). Membranes were blocked with 5% blotting-grade nonfat milk (Bio-Rad) in Trisbuffered saline with 0.1% Tween 20 (Sigma) for 1 h. Effector-CyaA fusion proteins were detected using
monoclonal antibody 3D1 against CyaA (Santa Cruz Biotechnology, Dallas, TX). As a reference protein,
GroL was detected using rabbit polyclonal antibody against E. coli GroL (Assay Designs, Ann Arbor, MI).
For detection, goat anti-mouse or goat anti-rabbit streptavidin–poly-horseradish peroxidase (HRP)
(Thermo Scientiﬁc) was used at a dilution of 1:10,000, followed by chemiluminescence detection using
the SuperSignal West Pico chemiluminescent substrate (Thermo Scientiﬁc).
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constructs were made by truncating the protein to eliminate the LRR region and the carboxy
terminus.

Edwardsiella ictaluri Translocated Effectors

Primer
eseG P1
eseG P2
eseG P3
eseI P1
eseI P2
eseI P3
eseH P1
treseH P2
eseH P3
eseJ P1
treseJ P2
eseJ P3
eseK P1
treseK P2
eseK P3
eseL P1
treseL P2
eseL P3
eseM P1
treseM P2
eseM P3
eseO P1
eseO P2
eseO P3
eseN P1
eseN P2
eseN P3
exoY P1
exoY P2
exoY P3
P4

Enzyme
XbaI

SacI

SacI

SacI

SacI

SacI

SacI

KpnI

KpnI

SacI

XbaI

Sequence 5=–3=
GTACGCTCGAGTCTAGATCGTCTAGAATCGGGCGCTGGATAAGATGCGACGACGCCTGAC
GCGTAACCAGCCTGATGCGATTGCTGAAAGAAGCATGCGGCAAAGCTGTGGCGTCGTGTC
GACACGACGCCACAGCTTTGCCGCATGCTTCTTTCAGCAATCGCATCAGGCTGGTTACGC
GCCGATGAGCTCTGGCTCCCTAATCCTGTCTTGCGGCGAGCGGTGGGGATGAATGCAACG
CGTTTGCGTAACCAGCCTGATGCGATTGCTGGAAGAAGCATGCGGCTGGGATGAAGACTC
GAGTCTTCATCCCAGCCGCATGCTTCTTCCAGCAATCGCATCAGGCTGGTTACGCAAACG
GCGACTGAGCTCAGCCATTCACGACACTGCATGACGGTCAGATTCAGC
CGTAACCAGCCTGATGCGATTGCTGTTTGGTGTTAGAGACATCCAGCCGGGTGTTATATC
ACACCCGGCTGGATGTCTCTAACACCAAACAGCAATCGCATCAGGCTGGTTACGC
GCCGATGAGCTCTCTAAATAGCAGCAGGTTCAGAGGAGTAAC
CGTTTGCGTAACCAGCCTGATGCGATTGCTGGCAGTGACGTAGCTTCCACACAG
TACTGTGTGGAAGCTACGTCACTGCCAGCAATCGCATCAGGCTGGTTACGCAAACG
GCCGATGAGCTCGTGATCTACACAACGAATGCTATCGAGT
GGCGGCGTTTGCGTAACCAGCCTGATGCGATTGCTGCAGTCCGGTGGGCAGCGGCGGCAG
CTGCCGCCGCTGCCCACCGGACTGCAGCAATCGCATCAGGCTGGTTACGCAAACGCCGCC
GCCGATGAGCTCATAGCGTAGGGTGTCGATGCTACAGCCGATC
GTTTGCGTAACCAGCCTGATGCGATTGCTGGAGAGAGACATTCAGCCACTGCAGTCCG
AACGGACTGCAGTGGCTGAATGTCTCTCTCCAGCAATCGCATCAGGCTGGTTACGCAAAC
GTACGCTCGAGTCTCTAGAAAATGGTCTGTACAACGCGGAGGTGATACACCGACAG
TTTGCGTAACCAGCCTGATGCGATTGCTGATGCATGCAGCGACGTAGCCGCAGCACTG
CAGTGCTGCGGCTACGTCGCTGCATGCATCAGCAATCGCATCAGGCTGGTTACGCAAA
GCCGATGGTACCCGGATCCTTTGTCATATCATTGTCTTCCCTCCTG
GTTTGCGTAACCAGCCTGATGCGATTGCTGTGTATGATTAGGGTCGTAGAGGTAAATCAC
GTGATTTACCTCTACGACCCTAATCATACACAGCAATCGCATCAGGCTGGTTACGCAAAC
GACGCTCGAGGTACCGTCTAGAAAGTTGAGCTGGAAGGTTTTCAGG
GCGTTTGCGTAACCAGCCTGATGCGATTGCTGCTCTGTCATTAAACGATAAAACGGCTCC
GGAGCCGTTTTATCGTTTAATGACAGAGCAGCAATCGCATCAGGCTGGTTACGCAAACGC
GCCGATGAGCTCGATATCAAGCTGGTTGCGGATACACGCGATG
CGTTTGCGTAACCAGCCTGATGCGATTGCTGTCTCGGTTTTGTTAACGGATC
TTAAATTAGATCCGTTAACAAAACCGAGACAGCAATCGCATCAGGCTGGTTACGCAAACG
GAGCGTACCTCTAGAAAAAATGGGGGATAACACCCCCATTATTGGCGTTCCACTGCGCCCAGCGACGGCCGCCGCCGCAATCCGGGTG

aPrimers

starting with “tr” indicate an LRR effector that is truncated by removal of the LRR and the carboxy terminus. Final letters in the primer name indicate the
primers identiﬁed in Fig. 6. Underlined sequences indicate the cyaA overlap. Bold sequences indicate the restriction enzyme named in the second column. Italics
in the P4 primer indicate the rho-independent transcriptional terminator from the B. subtilis yqfT gene (53).

Cell culture. For the macrophage studies, HKDM were isolated by the method of Booth et al. (3), and
viable counts were determined using trypan blue dye exclusion (58). Dissociated cells were suspended
to a ﬁnal concentration of 1 ⫻ 107 cells/ml in channel catﬁsh macrophage medium (CCMM), which
consists of RPMI 1640 medium (Gibco, Invitrogen Corporation, Carlsbad, CA) diluted to a catﬁsh tonicity
of 243 mosmol/kg by addition of 1 part sterile deionized/distilled water (RPMI 9:1) and contains 15 mM
HEPES buffer solution (Gibco), 0.18% sodium bicarbonate solution (Gibco), 0.05 mM 2-betamercaptoethanol (Sigma Chemicals Co., St. Louis, MO), and 5% heat-inactivated pooled channel catﬁsh
serum (58). One milliliter of the cell suspension was added to each well of a 24-well plate and allowed
to adhere for 16 h at 28°C with 5% CO2, after which the wells were washed three times with RPMI 9:1
to remove nonadherent cells and 1 ml of fresh CCMM was added per well. To evaluate replication, 1 ⫻
104 cells of either wild-type or mutant E. ictaluri that had been opsonized for 30 min in normal
autologous serum were added to triplicate wells of the 16-h HKDM cultures, giving a multiplicity of
infection (MOI) of 1 bacterium per 10 HKDM. After infection, plates were centrifuged at 400 ⫻ g to
synchronize the contact of the bacteria with the adhered cell layer and allowed to incubate for 30 min
at 28 C with 5% CO2. The medium was then removed from each well, and CCMM with 100 g/ml
gentamicin was added for 1 h to kill residual extracellular bacteria. Cells were then washed three times
with RPMI 9:1 and CCMM containing a 0.35-g/ml bacteriostatic dose of gentamicin to control the
extracellular growth of any bacteria released from the cells. At 0, 4, 8, or 10 h, depending on the assay,
the HKDM were lysed by the addition of 100 l of a 1% solution of Triton X-100 (Fisher Scientiﬁc, Fair
Lawn, NJ) and the numbers of surviving E. ictaluri cells were determined by spreading serial dilutions on
BA. A similar assay was done using the CCO cell line except that RPMI 1640 medium (Gibco) with 10%
fetal bovine serum, 25 mM HEPES, and 0.01 mM sodium pyruvate was used, cells were split and passaged
using standard cell culture methods, and the MOI was 1 bacterium per cell.
Translocation assay. Translocation of the effector-CyaA fusions from E. ictaluri in the ECV to the
cytoplasm was determined using both HKDM and CCO cells by measuring cAMP production. Brieﬂy,
duplicate wells of HKDM were infected at an MOI of 10 bacteria to 1 HKDM, and CCO cells were infected
at an MOI of 100:1. Following infection, any remaining extracellular bacteria were killed using 100 g/ml
of gentamicin. At 7 h postinfection, cells were lysed with 0.1 M HCl containing 0.1% Triton X-100. Levels
of cAMP produced by the interaction of the AC domain of the CyaA toxin with calmodulin in the host
cell cytoplasm were measured in picomoles of cAMP per milliliter by using the cAMP complete
enzyme-linked immunosorbent assay (ELISA) kit from Enzo Life Sciences (Plymouth Meeting, PA).
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TABLE 3 Primers used to construct the effector-cyaA fusions in this studya

Dubytska et al.

Primer
name
eseG P1
eseG P2
eseG P3
eseG P4
eseJ P1
eseJ P2
eseJ P3
eseJ P4
eseK P1
eseK P2
eseK P3
eseK P4
eseL P1
eseL P2
eseL P3
eseL P4
eseM P1
eseM P2
eseM P3
eseM P4
eseN P1
eseN P2
eseN P3
eseN P4
eseO P1
eseO P2
eseO P3
eseO P4

Sequence (restriction endonuclease)a
GAATCGTGTACAGGGTCGACGATGGATGACGTCAGCCGTTTC (SalI)
TGTGGCTTCGAGCTCAGCCATCCGTTCGTCTTAAGGTTGATTAAGCGTATCCAGCAG
CTGCTGGATACGCTTAATCAACCTTAAGACGAACGGATGGCTGAGCTCGAA GCCACAG
CACGATGCCTCTAGATACTGACGGTTTCACGGTTTTGTTCCTGGTTAAGA (XbaI)
GGACTATCTGAGCTCGGGGCCAGGAAACAGGACGTAACCCGACAGAC (SacI)
GCCACCGCTCACGGTTACCGCACGTAGTGAAATTTTCCCATTAATTCAGTTG
CAACTGAATTAATGGGAAAATTTCACTACGTGCGGTAACCGTGAGCGGTGGC
CACGATGCCTCTAGAAGTTAGAACTTAAAAAAACGCGGAACACATC (XbaI)
GGACTATCTGAGCTCTCTGGCTCAATGTGCTGACAGAGCTGAAG (SacI)
CTACCGACACGAGCCCCGGGATATCGTTAGTACAATTTTCCTATTGATTCATTGG
CCAATGAATCAATAGGAAAATTGTACTAACGATATCCCGGGGCTCGTGTCGGTAG
CACGATGCCTCTAGATCAGTTTATGCCAGGGAATGCTATACAGGGGACGCATC (XbaI)
GAATCGTGTACAGGGTCGACGAAAAAAATCTGCCGGGGTGGGTCAGGTC (SalI)
CGGCCACCGCTCACGGTTACCGCTCGTCTCATTTCCGGTGGGGTATTAGCGCTGGC
GCCAGCGCTAATACCCCACCGGAAATGAGACGAGCGGTAACCGTGAGCGGTGGCCG
CACGATGCCTCTAGATACTGGAACGGGTCGGTCATATCCCCCCGGCTG (XbaI)
GAATCGTGTACAGGGTCGACTCCCGAACTTCACTGTCAATCAATTTCATA (SalI)
CACCGCTCATGGTTACCGCACGTAGTGAAATTTTCCCATTAATTCAGTGG
CCACTGAATTAATGGGAAAATTTCACTACGTGCGGTAACCATGAGCGGTG
CACGATGCCTCTAGATTTCGACTTTACGCTGATCTTTGCTGAACCGTAGCGGATTTC (XbaI)
GAATCGTGTACAGGGTCGACTATCAGCATGGCTGCCTCTTTATAACCAGATAG (SalI)
CGCCTTCCGTCATCACCTCAGCGCTACGCGGGGGGCATCTTCTGCCTCCCGGCGGTAGGC
GCCTACCGCCGGGAGGCAGAAGATGCCCCCCGCGTAGCGCTGAGGTGATGACGGAAGGCG
CACGATGCCTCTAGACCTGAACTTTCTGCGCCCGTGGGTTATCGAGGCCTTCGGCGAC (XbaI)
GGACTATCTGAGCTCTGCAGCTTGTTGGTCGCCAGCGCCTGGGC (SacI)
CATATGGAATGACGCCTGTATCGTTAATAAAATATATTAATACCTTATGTTATCCTATC
GATAGGATAACATAAGGTATTAATATATTTTATTAACGATACAGGCGTCATTCCATATG
CACGATGCCTCTAGACATCACGGTCTGACCTGTCCTGCCATCACGTC (XbaI)

aUnderlined

sequences represent the overlapping sequences in P2 and P3 that mediate annealing of the two
amplicons to enable ampliﬁcation of the complete gene-deleted fragment with P1 and P4. Restriction
endonuclease sites to facilitate ﬁnal cloning of the gene-deleted fragment are in bold.

Production of cAMP was normalized by determining the protein concentration in each sample using the
Bio-Rad protein assay and calculating the number of picomoles of cAMP per milligram of protein.
Effect of vacuolar pH on translocation. To evaluate the requirement for initial acidiﬁcation of the
ECV, the translocation assay was done with all E. ictaluri effector-CyaA strains in HKDM cultured with a
10 nM concentration of the speciﬁc inhibitor of vacuolar H⫹ ATPases throughout the assay, baﬁlomycin
A1 (59). Untreated HKDM were used as a control. Cells were lysed 5 h p.i. and assayed for cAMP
production.
To prevent subsequent neutralization of the ECV, the translocation assay was also done with all
E. ictaluri effector-CyaA strains using HKDM cultured throughout the assay with a 10 mM concentration
of the speciﬁc arginase inhibitor norvaline. Untreated HKDM were used as a positive control. Cells were
lysed 5 h p.i. and assayed for cAMP production.
Replication in channel catﬁsh macrophages and channel catﬁsh ovary cells. Head kidneyderived macrophages were collected from channel catﬁsh, and CCO cells were maintained using

TABLE 5 Primers used for construction of the complementation plasmids
Primer
eseG P1
eseG P2
eseJ P1
eseJ P2
eseK P1
eseK P2
eseL P1
eseL P2
eseM P1
eseM P2
eseO P1
eseO P2
eseN P1
eseN P2
aRestriction

Enzyme
XbaI
SalI
SacI
HindIII
SacI
XhoI
SacI
HindIII
KPN
XbaI
KpnI
EcoRI
PstI
HindIII

Sequence 5=–3=a
GTACGCTCGAGTCTAGATCGTCTAGAATCGGGCGCTGGATAAGATGCGACGACGCCTGAC
GTACGCTCGATGCTGTCGACTCAGGCAAAGCTGTGGCGTCGTGTCAGTGGAGCAG
GCCGATGAGCTCTCTAAATAGCAGCAGGTTCAGAGGAGTAAC
GCCGCAAGCTTCGCCAGAGAATGATATACAGAGGACTCAGCTAACGAC
GCCGATGAGCTCGTGATCTACACAACGAATGCTATCGAGT
GTACGCTCGATGCTCGAGTCAGTTTATGCCAGGGAATGCTATACAGGGGACGCATCTAG
GCCGATGAGCTCATAGCGTAGGGTGTCGATGCTACAGCCGATC
GGCCGCAAGCTTCGCCAGAGAATGATATACAGAGGACTCAG
GTACGCTCGATGGGTACCAAATGGTCTGTACAACGCGGAGGTGATACACCGACAG
GTACGCTCGATGTCTAGACTCACAACTGCCGAACGTGGACTGACCTGAC
GCCGATGGTACCCGGATCCTTTGTCATATCATTGTCTTCCCTCCTG
GTACGCTCGATGCTGAATTCAGATGTAGGGGGCGACCATTCC
GTACGCTCGAGCTGCAGCGTCTAGAAAGTTGAGCTGGAAGGTTTTCAGG
GCCGCAAGCTTCTCTGTCATTAAACGATAAAACGGCTCCTCTCGTAATGCTTG

endonuclease sequences included to facilitate cloning are in bold.
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TABLE 4 Primers used for construction of the single-gene effector mutants

Edwardsiella ictaluri Translocated Effectors

standard cell culture techniques. For complementation, individual effectors and their promoter regions
were ampliﬁed by PCR using the primers in Table 5 and cloned into the stably expressed complementation plasmid PBBR1MCS-4 (54, 60), and the ﬁdelity of the ampliﬁed products was conﬁrmed by DNA
sequencing. Both cultures were infected with wild-type and mutant E. ictaluri strains, as well as the strains
carrying the corresponding complementation plasmid, and evaluated for replication using the gentamicin exclusion assay, with 3 to 4 replicate wells per treatment. Cell lysates were serially diluted after 10 h
and plated on BA plates, and numbers of CFU per well were determined. An index of replication was
calculated by dividing the number of CFU present in the individual mutants by the number of CFU
present in the wild type. Gentamicin exclusion experiments were repeated 3 to 4 times to establish
reproducibility.
Statistical analyses. All data analysis was done using the GraphPad Prism 5 software (GraphPad
Software, Inc., La Jolla, CA). Data for the norvaline experiment were analyzed by using the unpaired t test
to compare the treated and nontreated cultures for each effector-CyaA strain. Intracellular replication
data were analyzed using one-way analysis of variance with Dunnett’s multiple-comparison posttest.
Data for the in vitro pH shift experiment were analyzed by using a paired t test.
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